Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SYNERGY PHARMACEUTICALS, INC. | 1,010,000 | reported | 05 Jan 2018 | tx 2+480,000 |
| Dianthus Therapeutics, Inc. /DE/ | 269,408 | reported | 16 Mar 2026 | tx 16+1,521,210−311,128 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | EXERCISE | Dianthus Therapeutics, Inc. /DE/ | 59,700 | 6.70 USD | |
| 16 Mar 2026 | EXERCISE | Dianthus Therapeutics, Inc. /DE/ | 5,592 | 17.88 USD | |
| 16 Mar 2026 | EXERCISE | Dianthus Therapeutics, Inc. /DE/ | 59,700 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | Dianthus Therapeutics, Inc. /DE/ | 5,592 | 0.00 USD | deriv |
| 12 Mar 2026 | SALE | Dianthus Therapeutics, Inc. /DE/ | 65,517 | 81.74 USD | |
| 12 Mar 2026 | SALE | Dianthus Therapeutics, Inc. /DE/ | 43,505 | 80.69 USD | |
| 12 Mar 2026 | EXERCISE | Dianthus Therapeutics, Inc. /DE/ | 122,918 | 6.70 USD | |
| 12 Mar 2026 | SALE | Dianthus Therapeutics, Inc. /DE/ | 12,796 | 82.60 USD | |
| 12 Mar 2026 | SALE | Dianthus Therapeutics, Inc. /DE/ | 200 | 83.38 USD | |
| 12 Mar 2026 | SALE | Dianthus Therapeutics, Inc. /DE/ | 900 | 85.53 USD | |
| 12 Mar 2026 | EXERCISE | Dianthus Therapeutics, Inc. /DE/ | 122,918 | 0.00 USD | deriv |
| 03 Feb 2026 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 355,000 | 0.00 USD | deriv |
| 30 Sept 2025 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 120,000 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 340,000 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 243,000 | 0.00 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 275,000 | 0.00 USD | deriv |
| 05 Jan 2018 | GRANT_AWARD | SYNERGY PHARMACEUTICALS, INC. | 280,000 | 0.00 USD | deriv |
| 24 Jun 2016 | GRANT_AWARD | SYNERGY PHARMACEUTICALS, INC. | 200,000 | 0.00 USD | deriv |